In age subgroup (normal-vs-age (21–40 yrs), normal-vs-age (41–60 yrs), normal-vs-age (61–80 yrs) and normal-vs-age (81–100 yrs)) analysis the transcription level of INHBA was essentially higher in HNSCC patients than healthy individuals. The gene discussed is INHBA; the disease is head and neck squamous cell carcinoma.